Prosecution Insights
Prosecution Insights
6 pending office actions • 2 clients • 6 examiners • 5 art units • 0 of 6 (0%) have an AI response strategy ready
Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (17%) |
| Double-patenting + other | 1 (17%) |
| Multi-statute (no §101) | 4 (67%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| CHO, DAVID H | 1 | 37.5% | +73.5% |
| BRETZ, COREY LANE | 1 | 0.0% | +0.0% |
| LEE, RIP A | 1 | 83.5% | -4.3% |
| NGUYEN, KHANH TUAN | 1 | 74.4% | +18.7% |
| SCOTT, ANGELA C | 1 | 62.5% | +18.9% |
| TRAN, CHRISTINA L | 1 | 48.2% | +45.5% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17611761 | ORAL DELIVERY OF OLIGONUCLEOTIDES | TRAN, CHRISTINA L | 49d |
| 18142313 | PROCESS FOR MODIFYING AN OLEFIN POLYMER COMPOSITION AND PRODUCTS THEREOF | LEE, RIP A | 54d |
| 18259887 | 2'-MODIFIED NUCLEOSIDE BASED OLIGONUCLEOTIDE PRODRUGS | BRETZ, COREY LANE | 69d |
| 17983593 | ETHYLENE POLYMER BLEND COMPOSITION FOR ADDITIVE-MANUFACTURE FEEDSTOCK | SCOTT, ANGELA C | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17611761 | ORAL DELIVERY OF OLIGONUCLEOTIDES | TRAN, CHRISTINA L | 49d |
| 18613537 | 3'-OH RNA-CONTAINING OLIGONUCLEOTIDE DEPROTECTION | CHO, DAVID H | — |
| 18142234 | INORGANIC SOLID PARTICLE COMPOSITIONS AND METHODS OF MAKING AND USING THEREOF | NGUYEN, KHANH TUAN | — |
| 17983593 | ETHYLENE POLYMER BLEND COMPOSITION FOR ADDITIVE-MANUFACTURE FEEDSTOCK | SCOTT, ANGELA C | — |
| Client (Assignee) | Pending OAs |
|---|---|
| ALNYLAM PHARMACEUTICALS, INC. | 3 |
| Braskem | 3 |
| Art Unit | Apps |
|---|---|
| 1635 | 1 |
| 1762 | 1 |
| 1761 | 1 |
| 1767 | 1 |
| 1637 | 1 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 18613537 | 3'-OH RNA-CONTAINING OLIGONUCLEOTIDE DEPROTECTION | Alnylam Pharmaceuticals, Inc. | CHO, DAVID H | §102§103§112DP | Non-Final OA | — | Pending | Mar 22, 2024 | |
| 18259887 | 2'-MODIFIED NUCLEOSIDE BASED OLIGONUCLEOTIDE PRODRUGS | Alnylam Pharmaceuticals, Inc. | BRETZ, COREY LANE | 1635 | §102§103 | Non-Final OA | 69d | Pending | Jun 29, 2023 |
| 18142313 | PROCESS FOR MODIFYING AN OLEFIN POLYMER COMPOSITION AND PRODUCTS THEREOF | Braskem America, Inc. | LEE, RIP A | 1762 | §102§103 | Non-Final OA | 54d | Pending | May 02, 2023 |
| 18142234 | INORGANIC SOLID PARTICLE COMPOSITIONS AND METHODS OF MAKING AND USING THEREOF | Braskem America, Inc. | NGUYEN, KHANH TUAN | 1761 | §103 | Final Rejection | — | Pending | May 02, 2023 |
| 17983593 | ETHYLENE POLYMER BLEND COMPOSITION FOR ADDITIVE-MANUFACTURE FEEDSTOCK | Braskem America, Inc. | SCOTT, ANGELA C | 1767 | §102§103§112 | Non-Final OA | — | Pending | Nov 09, 2022 |
| 17611761 | ORAL DELIVERY OF OLIGONUCLEOTIDES | Alnylam Pharmaceuticals, Inc. | TRAN, CHRISTINA L | 1637 | §103§112Other | Final Rejection | 49d | Pending | Nov 16, 2021 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial